Michele Dowless

2.1k total citations
26 papers, 871 citations indexed

About

Michele Dowless is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Michele Dowless has authored 26 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Neurology. Recurrent topics in Michele Dowless's work include Neuroblastoma Research and Treatments (5 papers), Protein Degradation and Inhibitors (3 papers) and Cell Image Analysis Techniques (3 papers). Michele Dowless is often cited by papers focused on Neuroblastoma Research and Treatments (5 papers), Protein Degradation and Inhibitors (3 papers) and Cell Image Analysis Techniques (3 papers). Michele Dowless collaborates with scholars based in United States, Italy and France. Michele Dowless's co-authors include Louis F. Stancato, Wayne Blosser, Jennifer R. Stephens, Jeremy R. Graff, Bruce W. Konicek, Stephen H. Parsons, Ann M. McNulty, Chad A. Dumstorf, Jonathan Low and Blake Lee Neubauer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Michele Dowless

26 papers receiving 862 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michele Dowless United States	15	597	280	109	100	98	26	871
Christophe Frémin France	15	650 1.1×	201 0.7×	62 0.6×	107 1.1×	69 0.7×	17	1.0k
Robert Kiss Belgium	16	370 0.6×	142 0.5×	86 0.8×	113 1.1×	166 1.7×	26	715
Clark M. Whitehead United States	17	988 1.7×	380 1.4×	89 0.8×	178 1.8×	90 0.9×	24	1.5k
Lina Leiss Norway	11	386 0.6×	202 0.7×	139 1.3×	196 2.0×	152 1.6×	20	810
Jaya Sangodkar United States	19	1.0k 1.7×	243 0.9×	101 0.9×	200 2.0×	82 0.8×	24	1.3k
Jangsoon Lee United States	18	684 1.1×	434 1.6×	90 0.8×	166 1.7×	84 0.9×	40	1.1k
Pablo E. Hollstein United States	9	831 1.4×	253 0.9×	75 0.7×	141 1.4×	93 0.9×	10	1.1k
Robert L. Kortum United States	25	1.2k 2.0×	365 1.3×	73 0.7×	160 1.6×	343 3.5×	40	1.6k
Florian Uhlitz Germany	7	557 0.9×	252 0.9×	144 1.3×	193 1.9×	149 1.5×	8	846
Konstantinos V. Floros United States	16	707 1.2×	242 0.9×	158 1.4×	214 2.1×	71 0.7×	24	954

Countries citing papers authored by Michele Dowless

Since Specialization

Citations

This map shows the geographic impact of Michele Dowless's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Dowless with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Dowless more than expected).

Fields of papers citing papers by Michele Dowless

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Dowless. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Dowless. The network helps show where Michele Dowless may publish in the future.

Co-authorship network of co-authors of Michele Dowless

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Dowless. A scholar is included among the top collaborators of Michele Dowless based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Dowless. Michele Dowless is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mur, Cecilia, W K Shen, Carlos Marugán, et al.. (2023). 41P Preclinical characterization of imlunestrant, an oral brain-penetrant selective estrogen receptor degrader with activity in a brain metastasis (BM) model. ESMO Open. 8(1). 101265–101265. 1 indexed citations

Chen, Celine, Ana Isabel Enríquez Rodríguez, Jan Köster, et al.. (2022). Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours. European Journal of Cancer. 170. 196–208. 9 indexed citations

DuBois, Steven G., Jill D. Kremer, Bram De Wilde, et al.. (2020). A phase I study of Aurora kinase A inhibitor LY3295668 erbumine as a single agent and in combination in patients with relapsed/refractory neuroblastoma.. Journal of Clinical Oncology. 38(15_suppl). TPS10561–TPS10561. 2 indexed citations

Dowless, Michele, Caitlin D. Lowery, Terry J. Shackleford, et al.. (2018). Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling. Clinical Cancer Research. 24(23). 6028–6039. 47 indexed citations

Lowery, Caitlin D., Michele Dowless, Wayne Blosser, et al.. (2017). The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma. Clinical Cancer Research. 23(15). 4354–4363. 53 indexed citations

Lowery, Caitlin D., Wayne Blosser, Michele Dowless, et al.. (2017). Olaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor α. Clinical Cancer Research. 24(4). 847–857. 26 indexed citations

Peng, Sheng-Bin, Xiaoyi Zhang, Donald C. Paul, et al.. (2016). Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies. PLoS ONE. 11(3). e0150585–e0150585. 50 indexed citations

Tate, Courtney M., Roberto Pallini, Lucia Ricci‐Vitiani, et al.. (2012). A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells. Cell Death and Differentiation. 19(10). 1644–1654. 56 indexed citations

Meier, Timothy I., Mark Uhlik, Sudhakar Chintharlapalli, et al.. (2011). Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization. Molecular Cancer Therapeutics. 10(11). 2168–2178. 31 indexed citations

10.

Sutherland, Jeffrey J., Jonathan Low, Wayne Blosser, et al.. (2011). A Robust High-Content Imaging Approach for Probing the Mechanism of Action and Phenotypic Outcomes of Cell-Cycle Modulators. Molecular Cancer Therapeutics. 10(2). 242–254. 26 indexed citations

11.

Low, Jonathan, Wayne Blosser, Michele Dowless, et al.. (2011). Knockdown of Ubiquitin Ligases in Glioblastoma Cancer Stem Cells Leads to Cell Death and Differentiation. SLAS DISCOVERY. 17(2). 152–162. 10 indexed citations

12.

Konicek, Bruce W., Jennifer R. Stephens, Ann M. McNulty, et al.. (2011). Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases. Cancer Research. 71(5). 1849–1857. 159 indexed citations

13.

Low, Jonathan, Michele Dowless, Tatiyana L. Shiyanova, et al.. (2010). Knockdown of Cancer Testis Antigens Modulates Neural Stem Cell Marker Expression in Glioblastoma Tumor Stem Cells. SLAS DISCOVERY. 15(7). 830–839. 12 indexed citations

14.

Parsons, Stephen H., Michele Dowless, Bruce W. Konicek, et al.. (2010). 148 Therapeutic targeting of the pro-survival transcription factor CREB sensitizes glioblastomas to temozolomide-based therapy. European Journal of Cancer Supplements. 8(7). 52–53. 1 indexed citations

15.

Graff, Jeremy R., Bruce W. Konicek, Rebecca L. Lynch, et al.. (2009). eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival. Cancer Research. 69(9). 3866–3873. 156 indexed citations

16.

Low, Jonathan, et al.. (2009). Phenotypic Fingerprinting of Small Molecule Cell Cycle Kinase Inhibitors for Drug Discovery. PubMed. 3. 13–21. 19 indexed citations

17.

Low, Jonathan, Shuguang Huang, Michele Dowless, et al.. (2007). High-Content Imaging Analysis of the Knockdown Effects of Validated siRNAs and Antisense Oligonucleotides. SLAS DISCOVERY. 12(6). 775–788. 14 indexed citations

18.

Schmidt, Robert J., James Ficorilli, Youyan Zhang, et al.. (2006). A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity. Journal of Lipid Research. 47(5). 1037–1044. 14 indexed citations

19.

Dowless, Michele, et al.. (2005). Cyclic AMP-independent activation of CYP3A4 gene expression by forskolin. European Journal of Pharmacology. 512(1). 9–13. 12 indexed citations

20.

Bramlett, Kelli, Keith A. Houck, Michele Dowless, et al.. (2003). A Natural Product Ligand of the Oxysterol Receptor, Liver X Receptor. Journal of Pharmacology and Experimental Therapeutics. 307(1). 291–296. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact